Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus

Virology Journal

Volumn 8, Issue , 2011, Pages

  Harris, Katie ^a   Ream, Rebecca ^a   Gao, Jin ^a   Eichelberger, Maryna C ^a  

^a Center for Biologics Evaluation and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBODY; GAMMA INTERFERON; HEMAGGLUTININ SPECIFIC ANTIBODY; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INTERLEUKIN 12; NUCLEOPROTEIN; UNCLASSIFIED DRUG; CORE PROTEIN; CYTOKINE; INACTIVATED VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; LIVE VACCINE; NP PROTEIN, INFLUENZA A VIRUS; RNA BINDING PROTEIN; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; DRUG EFFICACY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA A (H3N2); INNATE IMMUNITY; MOUSE; NONHUMAN; ANIMAL; BAGG ALBINO MOUSE; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; IMMUNOLOGY; INFLUENZA VIRUS A H3N2; INTRAMUSCULAR DRUG ADMINISTRATION; METHODOLOGY; ORTHOMYXOVIRUS INFECTION; RODENT DISEASE;

MUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIBODIES, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNIZATION; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; RNA-BINDING PROTEINS; RODENT DISEASES; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VIRAL CORE PROTEINS;

EID: 79956212139     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-251     Document Type: Article

References (29)

1. The underrecognized burden of influenza in young children. KA Poehling KM Edwards GA Weinberg,, et al. N Engl J Med 2006 355 31 10.1056/NEJMoa054869 16822994
2. The impact of influenza epidemics on mortality: introducing a severity index. L Simonsen MJ Clarke GD Williamson DF Stroup NH Arden LB Schonberger, Am J Pub Health 1997 87 1944 10.2105/AJPH.87.12.1944
3. Antivirals and influenza: frequency of resistance. AS Monto, Pediatr Infect Dis J 2008 27 110 10.1097/INF.0b013e318168b739 18820569
4. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008. American Academy of Pediatrics Committee on Infectious Diseases, Pediatrics 2008 121 1016 18381500
5. A comparison of 2 influenza vaccine schedules in 6-23-month-old children. JA Englund EB Walter MP Fairchok AS Monto KM Neuzil, Pediatrics 2005 115 1039 10.1542/peds.2004-2373 15805382
6. Influenza Vaccination Coverage Among Children Aged 6 - 23 Months - United States, 2006 - 07 Influenza Season. CDC, MMWR 2008 57 1039 18818583
7. Innate immunity to virus infection. O Takeuchi S Akira, Immunol Rev 2009 227 75 10.1111/j.1600-065X.2008.00737.x 19120477
8. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. EM Creagh LA O'Neill, Trends Immunol 2006 27 352 10.1016/j.it.2006.06.003 16807108
9. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. N Schmitz M Kurrer MF Bachmann M Kopf, J Virol 2005 79 6441 10.1128/JVI.79.10.6441-6448.2005 15858027
10. Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. RJ Cox KA Brokstad P Ogra, Scand J Immunol 2004 59 1 10.1111/j.0300-9475.2004.01382.x 14723616
11. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. S Sasaki MC Jaimes TH Homes CL Dekker MK Kemble AM Arvin HB Greenberg, J Virol 2007 81 215 10.1128/JVI.01957-06 17050593
12. Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor. MC Eichelberger GA Prince MG Ottolini, Virology 2004 322 300 10.1016/j.virol.2004.01.032 15110527
13. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization. D Marshall R Sealy M Sangster C Coleclough, J Immunol 1999 163 4673 10528164
14. Matching antibody class with pathogen type and portal of entry: cognate mechanisms regulate local isotype expression patterns in lymph nodes draining the respiratory tract of mice inoculated with respiratory viruses, according to virus replication competence and site of inoculation. MY Sangster XY Mo R Sealy C Coleclough, J Immunol 1997 159 1893 9257854
15. + T cells in primary and secondary influenza pneumonia. KJ Flynn GT Belz JD Altman R Ahmed DL Woodland PC Doherty, Immunity 1998 8 683 10.1016/S1074-7613(00)80573-7 9655482
16. Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells. PM Taylor J Davey K Howland JB Rothbard BA Askonas, Immunogenetics 1987 26 267 10.1007/BF00346521 2443447
17. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza virus vaccine in young children with recurrent respiratory tract infections. S Ashkenazi A Vertruyen J Arístegui S Esposito DD McKeith T Klemola J Biolek J Kühr T Bujnowski D Desgrandchamps SM Cheng J Skinner WC Gruber BD Forrest the CAIV-T Study Group, Pediatr Infect Dis J 2006 25 870 879 10.1097/01.inf.0000237829.66310.85 17006279 (Pubitemid 44510578)
18. Live attenuated versus inactivated influenza virus vaccine in infants and young children. RB Belshe KM Edwards T Vesikari SV Black RE Walker M Hultquist G Kemble M Connor the CAIV-T Comparative Efficacy Study Group, N Engl J Med 2007 356 685 696 10.1056/NEJMoa065368 17301299
19. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies. DC Powers BR Murphy LF Fries WH Adler ML Clements, J Am Geriat Soc 1992 40 163 167 1740601
20. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. BD Forrest MW Pride AJ Dunning MR Capeding T Chotpitayasunondh JS Tam R Rappaport JH Eldridge WC Gruber, Clin Vaccine Immunol 2008 15 1042 53 10.1128/CVI.00397-07 18448618 (Pubitemid 352018317)
21. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. M Mibayashi L Martínez-Sobrido YM Loo WB Cárdenas M Gale A García-Sastre, J Virol 2007 81 514 10.1128/JVI.01265-06 17079289
22. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. G Gautier M Humbert F Deauvieau M Scuiller J Hiscott EE Bates G Trinchieri C Caux P Garrone, J Exp Med 2005 201 1435 10.1084/jem.20041964 15851485
23. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses. K Fink KS Lang N Manjarrez-Orduno T Junt BM Senn M Holdener S Akira RM Zinkernagel H Hengartner, Eur J Immunol 2006 36 2094 10.1002/eji.200635993 16810635
24. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. A Le Bon C Thompson E Kamphuis V Durand C Rossmann U Kalinke DF Tough, J Immunol 2006 176 2074 16455962
25. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. ES Coro WL Chang N Baumgarth, J Immunol 2006 176 4343 16547272
26. Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations. M Vajdy M Singh M Ugozzoli M Briones E Soenawan L Cuadra J Kazzaz P Ruggiero S Peppoloni F Norelli G del Giudice D O'Hagan, Immunology 2003 110 86 10.1046/j.1365-2567.2003.01711.x 12941145
27. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. KB Renegar PA Small Jr LG Boykins PF Wright, J Immunol 2004 173 1978 15265932
28. Measles elimination in the United States. WA Orenstein MJ Papania ME Wharton, J Infect Dis 2004 189 1 10.1086/377693 15106120
29. Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps and rubella immunization. H Sato P Albrecht DW Reynolds S Stagno FA Ennis, Am J Dis Child 1979 133 1240 229727